The researchers found that 14 gut bacterial taxa may contribute to the risks for insomnia, while a protective effect on this condition was seen for 8 gut bacterial taxa. HealthDay News — There appear ...

The Food and Drug Administration (FDA) has approved Brinsupri ™ (brensocatib) for the treatment of non-cystic fibrosis bronchiectasis (NCFB) in adult and pediatric patients aged 12 years and older.

This month’s case involves a PA who asked the court to dismiss a medical malpractice case, claiming that he had warned the patient of the need to go to the hospital. The court, however, cited Dead Man ...